Selective delivery of curcumin to breast cancer cells by self-targeting apoferritin nanocages with pH-responsive and low toxicity

References

• Alven S, Aderibigbe BA. (2020). Efficacy of polymer-based nanocarriers for co-delivery of curcumin and selected anticancer drugs. Nanomaterials 10:1556.
   Web of Science ®Google Scholar
• Chen Q, Fang H, Shao X, et al. (2020a). A dual-labeling probe to track functional mitochondria–lysosome interactions in live cells. Nat Commun 11:6290.
   PubMed Web of Science ®Google Scholar
• Chen Q, Shao X, Hao M, et al. (2020b). Quantitative analysis of interactive behavior of mitochondria and lysosomes using structured illumination microscopy. Biomaterials 250:120059.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhai M, Xie X, et al. (2017). Apoferritin nanocage for brain targeted doxorubicin delivery. Mol Pharm 14:3087–97.
   PubMed Web of Science ®Google Scholar
• Cheng C, Sui B, Wang M, et al. (2020). Carrier-free nanoassembly of curcumin–erlotinib conjugate for cancer targeted therapy. Adv Healthc Mater 9:e2001128.
   PubMed Web of Science ®Google Scholar
• Geninatti Crich S, Cadenazzi M, Lanzardo S, et al. (2015). Targeting ferritin receptors for the selective delivery of imaging and therapeutic agents to breast cancer cells. Nanoscale 7:6527–33.
   PubMed Web of Science ®Google Scholar
• He J, Fan K, Yan X. (2019). Ferritin drug carrier (FDC) for tumor targeting therapy. J Control Release 311–312:288–300.
   PubMed Web of Science ®Google Scholar
• He L, Qing F, Li M, Lan D. (2020). Paclitaxel/IR1061-co-loaded protein nanoparticle for tumor-targeted and pH/NIR-II-triggered synergistic photothermal-chemotherapy. Int J Nanomedicine 15:2337–49.
   PubMed Web of Science ®Google Scholar
• Inoue I, Chiba M, Ito K, et al. (2021). One-step construction of ferritin encapsulation drugs for cancer chemotherapy. Nanoscale 13:1875–83.
   PubMed Web of Science ®Google Scholar
• Jain V, Kumar H, Anod HV, et al. (2020). A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer. J Control Release 326:628–47.
   PubMed Web of Science ®Google Scholar
• Ji P, Huang H, Yuan S, et al. (2019). ROS-mediated apoptosis and anticancer effect achieved by artesunate and auxiliary Fe(II) released from ferriferous oxide-containing recombinant apoferritin. Adv Healthc Mater 8:e1900911.
   PubMed Web of Science ®Google Scholar
• Ji P, Wang L, Chen Y, et al. (2020a). Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution. Biomater Sci 8:462–72.
   PubMed Web of Science ®Google Scholar
• Ji P, Wang L, Wang S, et al. (2020b). Hyaluronic acid-coated metal-organic frameworks benefit the ROS-mediated apoptosis and amplified anticancer activity of artesunate. J Drug Target 28:1096–109.
   PubMed Web of Science ®Google Scholar
• Kim KR, You SJ, Kim HJ, et al. (2021). Theranostic potential of biodegradable polymeric nanoparticles with paclitaxel and curcumin against breast carcinoma. Biomater Sci 9:3750–61.
   PubMed Web of Science ®Google Scholar
• Kim M, Rho Y, Jin KS, et al. (2011). pH-dependent structures of ferritin and apoferritin in solution: disassembly and reassembly. Biomacromolecules 12:1629–40.
   PubMed Web of Science ®Google Scholar
• Kuang G, Lu H, He S, et al. (2021). Near-infrared light-triggered polyprodrug/siRNA loaded upconversion nanoparticles for multi-modality imaging and synergistic cancer therapy. Adv Healthcare Mater;
   Web of Science ®Google Scholar
• Kumari P, Paul M, Bobde Y, et al. (2020). Albumin-based lipoprotein nanoparticles for improved delivery and anticancer activity of curcumin for cancer treatment. Nanomedicine 15:2851–69.
   PubMed Web of Science ®Google Scholar
• Li G, Fang S, Shao X, et al. (2021). Curcumin reverses NNMT-induced 5-fluorouracil resistance via increasing ROS and cell cycle arrest in colorectal cancer cells. Biomolecules 11:1295.
   PubMed Web of Science ®Google Scholar
• Liang M, Fan K, Zhou M, et al. (2014). H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection. Proc Natl Acad Sci U S A 111:14900–5.
   PubMed Web of Science ®Google Scholar
• Lin CY, Yang SJ, Peng CL, Shieh MJ. (2018). Panitumumab-conjugated and platinum-cored pH-sensitive apoferritin nanocages for colorectal cancer-targeted therapy. ACS Appl Mater Interfaces 10:6096–106.
   PubMed Web of Science ®Google Scholar
• Liu W, Lin Q, Fu Y, et al. (2020). Target delivering paclitaxel by ferritin heavy chain nanocages for glioma treatment. J Control Release 323:191–202.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang C, Wei Y, et al. (2021). De novo-designed landmine warfare strategy luminophore for super-resolution imaging reveal ONOO– evolution in living cells. Chem Eng J 422:130151.
   Web of Science ®Google Scholar
• Lollo G, Ullio-Gamboa G, Fuentes E, et al. (2018). In vitro anti-cancer activity and pharmacokinetic evaluation of curcumin-loaded lipid nanocapsules. Mater Sci Eng C Mater Biol Appl 91:859–67.
   PubMed Web of Science ®Google Scholar
• Luan T, Cheng L, Cheng J, et al. (2019). Tailored design of an ROS-responsive drug release platform for enhanced tumor therapy via "sequential induced activation processes". ACS Appl Mater Interfaces 11:63.
   Web of Science ®Google Scholar
• Ma Y, Li R, Dong Y, et al. (2021). tLyP-1 peptide functionalized human H chain ferritin for targeted delivery of paclitaxel. Int J Nanomedicine 16:789–802.
   PubMed Web of Science ®Google Scholar
• Ma Z, Wang N, He H, Tang X. (2019). Pharmaceutical strategies of improving oral systemic bioavailability of curcumin for clinical application. J Control Release 316:359–80.
   PubMed Web of Science ®Google Scholar
• Madhusudana Rao K, Krishna Rao KS, Ramanjaneyulu G, Ha CS. (2015). Curcumin encapsulated pH sensitive gelatin based interpenetrating polymeric network nanogels for anti cancer drug delivery. Int J Pharm 478:788–95.
   PubMed Web of Science ®Google Scholar
• Mahmoudi R, Ashraf Mirahmadi-Babaheidri S, Delaviz H, et al. (2021). RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells. J Biomater Appl 35:743–53.
   PubMed Web of Science ®Google Scholar
• Mansourizadeh F, Alberti D, Bitonto V, et al. (2020). Efficient synergistic combination effect of quercetin with curcumin on breast cancer cell apoptosis through their loading into Apo ferritin cavity. Colloids Surf B Biointerfaces 191:110982
   PubMed Web of Science ®Google Scholar
• Pandolfi L, Bellini M, Vanna R, et al. (2017). H-ferritin enriches the curcumin uptake and improves the therapeutic efficacy in triple negative breast cancer cells. Biomacromolecules 18:3318–30.
   PubMed Web of Science ®Google Scholar
• Sampath M, Pichaimani A, Kumpati P, Sengottuvelan B. (2020). The remarkable role of emulsifier and chitosan, dextran and PEG as capping agents in the enhanced delivery of curcumin by nanoparticles in breast cancer cells. Int J Biol Macromol 162:748–61.
   PubMed Web of Science ®Google Scholar
• Singh RK, Patel KD, Mahapatra C, et al. (2019). Combinatory cancer therapeutics with nanoceria-capped mesoporous silica nanocarriers through pH-triggered drug release and redox activity. ACS Appl Mater Interfaces 11:288–99.
   PubMed Web of Science ®Google Scholar
• Vankayala R, Mac JT, Burns JM, et al. (2019). Biodistribution and toxicological evaluation of micron- and nano-sized erythrocyte-derived optical particles in healthy Swiss Webster mice. Biomater Sci 7:2123–33.
   PubMed Web of Science ®Google Scholar
• Wang KN, Shao X, Tian Z, et al. (2021). A continuous add-on probe reveals the nonlinear enlargement of mitochondria in light-activated oncosis. Adv Sci 8:e2004566.
   Web of Science ®Google Scholar
• Wei Y, Kong L, Chen H, et al. (2022). Super-resolution image-based tracking of drug distribution in mitochondria of a label-free naturally derived drug molecules. Chem Eng J 429:132134.
   Web of Science ®Google Scholar
• Xiao K, Liu Q, Suby N, et al. (2021). LHRH-targeted redox-responsive crosslinked micelles impart selective drug delivery and effective chemotherapy in triple-negative breast cancer. Adv Healthc Mater 10:e2001196.
   PubMed Web of Science ®Google Scholar
• Ye QN, Wang Y, Shen S, et al. (2021b). Biomaterials-based delivery of therapeutic antibodies for cancer therapy. Adv Healthc Mater 10:e2002139.
   PubMed Web of Science ®Google Scholar
• Ye Z, Chen D, Zheng R, et al. (2021b). Curcumin induced G2/M cycle arrest in SK-N-SH neuroblastoma cells through the ROS-mediated p53 signaling pathway. J Food Biochem 45:e13888.
   PubMed Web of Science ®Google Scholar
• Yin L, Meng Z, Zhang Y, et al. (2018). Bacillus spore-based oral carriers loading curcumin for the therapy of colon cancer. J Control Release 271:31–44.
   PubMed Web of Science ®Google Scholar
• Yu S, Wang S, Xie Z, et al. (2021). Hyaluronic acid coating on the surface of curcumin-loaded ZIF-8 nanoparticles for improved breast cancer therapy: an in vitro and in vivo study. Colloids Surf B Biointerfaces 203:111759.
   PubMed Web of Science ®Google Scholar
• Yue H, Huang R, Shan Y, Xing D. (2020). Delivery of Cas13a/crRNA by self-degradable black phosphorus nanosheets to specifically inhibit Mcl-1 for breast cancer therapy. J Mater Chem B 8:11096–106.
   PubMed Web of Science ®Google Scholar